Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway

Oncogene volume 20, pages 6597–6606 (2001)Cite this article

Abstract

We have developed ribozymes (Rz) that inhibit BRCA1 expression in order to study the role of this gene in chemosensitivity. Two Rz, targeting positions 358 or 5282 of the BRCA1 mRNA, were cloned into the retroviral vector LXSN and lipofected into the breast cancer cell-line HBL100. We obtained 79–99% inhibition of BRCA1 expression, as determined by real-time quantitative PCR and by Western blotting. Decreased expression of BRCA1 led to sensitivity to the DNA damaging agents cisplatin and etoposide, resistance to the microtubule-interfering agents (MIA) taxol and vincristine. The molecular mechanism of resistance to MIA was investigated further by determining the status of the JNK pathway. We found that JNK1 expression was elevated, while JNK2 expression was decreased in Rz-expressing clones compared to controls. We have quantified the mRNA levels of BRCA1, JNK1, 2, MEK-4, -7 and c-jun after treatment with MIA. Vincristine treatment of control cells resulted in transcriptional repression of BRCA1, while the JNK1, 2, MEK-4, -7 and c-jun genes were induced. In Rz-treated cells, only JNK1 and MEK-4 were expressed and none was induced after MIA treatment. We then studied the phosphorylation of c-jun, a downstream effector of the JNK pathway. We observed a strong increase in phosphorylated c-jun after MIA treatment of the control cells but not in BRCA1-Rz treated cells, suggesting inhibition of the JNK pathway. These results show that the BRCA1-JNK pathway is involved in the cytotoxic response to MIA treatment, and inhibition of BRCA1 leads to transcriptional modifications of the JNK pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT . 1999 J. Biol. Chem. 274: 18808–18812

  • Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD . 1998 Nat. Genet. 19: 254–256

  • Andres JL, Fan S, Turkel GJ, Wang JA, Twu NF, Yuan RQ, Lamszus K, Goldberg ID, Rosen EM . 1998 Oncogene 16: 2229–2241

  • Chapman MS, Verma IM . 1996 Nature 382: 678–679

  • Chen J . 2000 Cancer Res. 60: 5037–5039

  • Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R . 1998 Mol. Cell. 2: 317–328

  • Chen JJ, Silver D, Cantor S, Livingston DM, Scully R . 1999 Cancer Res. 59: 1752s–1756s

  • Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH . 1996 Cancer Res. 56: 3168–3172

  • Cortez D, Wang Y, Qin J, Elledge SJ . 1999 Science 286: 1162–1166

  • Fan S, Twu NF, Wang JA, Yuan RQ, Andres J, Goldberg ID, Rosen EM . 1998a Int. J. Cancer 77: 600–609

  • Fan S, Wang JA, Yuan RQ, Ma YX, Meng Q, Erdos MR, Brody LC, Goldberg ID, Rosen EM . 1998b Oncogene 16: 3069–3082

  • Forster AC, Symons RH . 1987 Cell 49: 211–220

  • Fromes Y, Gounon P, Veitia R, Bissery MC, Fellous A . 1996 J. Protein Chem. 15: 377–388

  • Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA . 1999 Cell 97: 575–586

  • Hsu LC, White RL . 1998 Proc. Natl. Acad. Sci. USA 95: 12983–12988

  • Husain A, He G, Venkatraman ES, Spriggs DR . 1998 Cancer Res. 58: 1120–1123

  • Jaeger JA, Turner DH, Zuker M . 1989 Proc. Natl. Acad. Sci. USA 86: 7706–7710

  • Lee JS, Collins KM, Brown AL, Lee CH, Chung JH . 2000 Nature 404: 201–204

  • Lee LF, Li G, Templeton DJ, Ting JP . 1998 J. Biol. Chem. 273: 28253–28260

  • Li S, Chen PL, Subramanian T, Chinnadurai G, Tomlinson G, Osborne CK, Sharp ZD, Lee WH . 1999 J. Biol. Chem. 274: 11334–11338

  • Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH . 1994 Science 266: 66–71

  • Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H . 1998 Proc. Natl. Acad. Sci. USA 95: 2302–2306

  • Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM . 2000 Proc. Natl. Acad. Sci. USA 97: 1020–1025

  • Rao VN, Shao N, Ahmad M, Reddy ES . 1996 Oncogene 12: 523–528

  • Rossi JJ . 1999 Chem. Biol. 6: R33–R37

  • Ruffner DE, Stomo GD, Uhlenbeck OC . 1990 Biochemistry 29: 10695–10702

  • Ruffner H, Verma IM . 1997 Prod. Natl. Acad. Sci. USA 94: 7138–7143

  • Schlegel BP, Green VJ, Ladias JA, Parvin JD . 2000 Proc. Natl. Acad. Sci. USA 97: 3148–3153

  • Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD . 1997a Proc. Natl. Acad. Sci. USA 94: 5605–5610

  • Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM . 1997b Cell 90: 425–435

  • Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM . 1997c Cell 88: 265–275

  • Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Wu GS, Licht JD, Weber BL, El-Deiry WS . 1997 Nature 389: 187–190

  • Thangaraju M, Kaufmann SH, Couch FJ . 2000 J. Biol. Chem. 275: 33487–33496

  • Tomlinson GE, Chen TT, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF . 1998 Cancer Res. 58: 3237–3242

  • Uhlenbeck OC . 1987 Nature 328: 596–600

  • Vaish NK, Kore AR, Eckstein F . 1998 Nucleic Acids Res. 26: 5237–5242

  • Wang Q, Zhang H, Kajino K, Greene MI . 1998a Oncogene 17: 1939–1948

  • Wang TH, Popp DM, Wang HS, Saitoh M, Mural JG, Henley DC, Ichijo H, Wimalasena J . 1999 J. Biol. Chem. 274: 8208–8216

  • Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T, Wimalasena J . 1998b J. Biol. Chem. 273: 4928–4936

  • Wang TH, Wang HS, Soong YK . 2000 Cancer 88: 2619–2628

  • Welcsh PL, Owens KN, King MC . 2000 Trends Genet. 16: 69–74

  • Wong AK, Ormonde PA, Pero R, Chen Y, Lian L, Salada G, Berry S, Lawrence Q, Dayananth P, Ha P, Tavtigian SV, Teng DH, Bartel PL . 1998 Oncogene 17: 2279–2285

  • Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX . 1999 Mol. Cell. 3: 389–395

  • Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R . 1998 J. Biol. Chem. 273: 25388–25392

  • Zhang CC, Yang JM, Bash-Babula J, White E, Murphy M, Levine AJ, Hait WN . 1999 Cancer Res. 59: 3663–3670

  • Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee WH . 1999 Science 285: 747–750

  • Zuker M . 1989 Science 244: 48–52

Download references

Acknowledgements

We thank N Uhrhammer for critically reading the manuscript. S Lafarge and V Sylvain were supported by doctoral fellowships from Association pour la Recherche contre le Cancer, Villejuif, Paris. This work was partly supported by the Ligue Nationale Contre le Cancer and its departmental committees of Puy de Dôme and Cantal.

Author information

Authors and Affiliations

  1. Laboratoire d'Oncologie Moléculaire, Centre Jean Perrin, BP 392, Clermont-Ferrand cedex, 63011, 1, France

    Stéphane Lafarge, Valérie Sylvain & Yves-Jean Bignon

  2. UNCM, INRA-Theix, 63122, Saint, Genes-Champanelle, France

    Marc Ferrara

Authors
  1. Stéphane Lafarge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valérie Sylvain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc Ferrara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yves-Jean Bignon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yves-Jean Bignon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lafarge, S., Sylvain, V., Ferrara, M. et al. Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway. Oncogene 20, 6597–6606 (2001). https://doi.org/10.1038/sj.onc.1204812

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204812

Keywords

This article is cited by

Search

Advanced search

Quick links